| dc.contributor.author |
Torres-García B.L., Castro-Pastrana L.I., Rodríguez-Rodríguez S., Estrada-Marín L., Cedillo-Carvallo B., Guzmán-García O., Ruíz-Argüelles A. |
|
| dc.date.accessioned |
2020-12-11T06:40:51Z |
|
| dc.date.available |
2020-12-11T06:40:51Z |
|
| dc.date.issued |
2018 |
|
| dc.identifier.issn |
2-s2.0-85041838372 |
|
| dc.identifier.uri |
http://repositorio.udlap.mx/xmlui/handle/123456789/13425 |
|
| dc.description.abstract |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041838372&doi=10.1007%2fs40290-017-0217-3&partnerID=40&md5=2b2fa2cca6d413bf6506590388ca0c79 |
|
| dc.source |
Pharmaceutical Medicine |
|
| dc.title |
Gini Index-Based Maximum Concentration and Area Under the Curve Split Points for Analysing Adverse Event Occurrence in Bioequivalence Studies |
|
| dc.type |
Article |
|